Advancing animal models of neoplasia through in vivo bioluminescence imaging

European Journal of Cancer

Volumn 38, Issue 16, 2002, Pages 2128-2136

  Edinger, M ^a   Cao, Y A ^a   Hornig, Y S ^b   Jenkins, D E ^b   Verneris, M R ^a   Bachmann, M H ^a,b   Negrin, R S ^a   Contag, C H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Xenogen Corporation   (United States)

Author keywords

Animal model; Bioluminescence; Imaging; In vivo; Tumour

Indexed keywords

BIOLUMINESCENCE; CANCER CHEMOTHERAPY; CANCER RESEARCH; CARCINOGENESIS; IMAGING SYSTEM; IN VIVO STUDY; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0036839884     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00410-0     Document Type: Article

References (36)

1. Resor L., Bowen T.J., Wynshaw-Boris A. Unraveling human cancer in the mouse. recent refinements to modeling and analysis Hum. Mol. Genet. 10:2001;669-675.
2. Weissleder R., Mahmood U. Molecular imaging. Radiology. 219:2001;316-333.
3. Hastings J.W. Chemistries and colors of bioluminescent reactions. a review Gene. 173:1996;5-11.
4. Wood K.V. Marker proteins for gene expression. Curr. Opin. Biotechnol. 6:1995;50-58.
5. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:1997;313-319.
6. Lipshutz G.S., Gruber C.A., Cao Y., Hardy J., Contag C.H., Gaensler K.M. In utero delivery of adeno-associated viral vectors. intraperitoneal gene transfer produces long-term expression Mol. Ther. 3:2001;284-292.
7. Rehemtulla A., Stegman L.D., Cardozo S.J.et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:2000;491-495.
8. Colin M., Moritz S., Schneider H., Capeau J., Coutelle C., Brahimi-Horn M.C. Haemoglobin interferes with the ex vivo luciferase luminescence assay. consequence for detection of luciferase reporter gene expression in vivo Gene Ther. 7:2000;1333-1336.
9. Francis K.P., Joh D., Bellinger-Kawahara C., Hawkinson M.J., Purchio T.F., Contag P.R. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68:2000;3594-3600.
10. Lee S.H., Camilli A. Novel approaches to monitor bacterial gene expression in infected tissue and host. Curr. Opin. Microbiol. 3:2000;97-101.
11. Loimaranta V., Tenovuo J., Koivisto L., Karp M. Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob. Agents Chemother. 42:1998;1906-1910.
12. Contag C.H., Spilman S.D., Contag P.R.et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:1997;523-531.
13. Contag C.H., Contag P.R., Mullins J.I., Spilman S.D., Stevenson D.K., Benaron D.A. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:1995;593-603.
14. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6(4), 432-440.
15. Contag C.H., Jenkins D., Contag P.R., Negrin R.S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2:2000;41-52.
16. Zhang L., Hellstrom K.E., Chen L. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin. Exp. Metastasis. 12:1994;87-92.
17. Edinger M., Sweeney T.J., Tucker A.A., Olomu A.B., Negrin R.S., Contag C.H. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1:1999;303-310.
18. Sweeney T.J., Mailander V., Tucker A.A.et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. USA. 96:1999;12044-12049.
19. Tuchin V. Laser light scattering in biomedical diagnostics and therapy. J Laser Appl 1993, 5, 43-60.
20. Wu J.C., Sundaresan G., Iyer M., Gambhir S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 4:2001;297-306.
21. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
22. Lu P.H., Negrin R.S. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J. Immunol. 153:1994;1687-1696.
23. Hoyle C., Bangs C.D., Chang P., Kamel O., Mehta B., Negrin R.S. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients. in vitro and in vivo efficacy in severe combined immunodeficiency disease mice Blood. 92:1998;3318-3327.
24. Baker J., Verneris M.R., Ito M., Shizuru J.A., Negrin R.S. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood. 97:2001;2923-2931.
25. Scheffold C, Scheffold YC, Kornacker M, Contag CH, Negrin RS. Real time kinetics of HER-2/new targeted cell therapy in living animals. Can Res, in press.
26. Nakajima A., Seroogy C.M., Sandora M.R.et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107:2001;1293-1301.
27. Costa G.L., Sandora M.R., Nakajima A.et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via t cell delivery of the IL-12 p40 subunit. J. Immunol. 167:2001;2379-2387.
28. Day RN, Kawecki M, Berry D. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques 1998, 25, 848-850, 852-854, 856.
29. Rocchetta H.L., Boylan C.J., Foley J.W.et al. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob. Agents Chemother. 45:2001;129-137.
30. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods. 14:1998;381-392.
31. Kistner A., Gossen M., Zimmermann F.et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci USA. 93:1996;10933-10938.
32. Berns A. Turning on tumors to study cancer progression. Nat. Med. 5:1999;989-990.
33. Ewald D., Li M., Efrat S.et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science. 273:1996;1384-1386.
34. Chin L., Tam A., Pomerantz J.et al. Essential role for oncogenic Ras in tumour maintenance. Nature. 400:1999;468-472.
35. Engebrecht J., Simon M., Silverman M. Measuring gene expression with light. Science. 227:1985;1345-1347.
36. Doubrovin M., Ponomarev V., Beresten T.et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl. Acad. Sci. USA. 98:2001;9300-9305.